Literature DB >> 18519518

FDG-positron-emission tomography for staging and therapeutic assessment in patients with plasmacytoma.

Pierre-Yves Salaun, Thomas Gastinne, Eric Frampas, Caroline Bodet-Milin, Philippe Moreau, Françoise Bodéré-Kraeber.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18519518     DOI： 10.3324/haematol.12654

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  16 in total

Review 1.  The role of positron emission tomography-computed tomography and magnetic resonance imaging in diagnosis and follow up of multiple myeloma.

Authors:  Jo Caers; Nadia Withofs; Jens Hillengass; Paolo Simoni; Elena Zamagni; Roland Hustinx; Yves Beguin
Journal:  Haematologica       Date:  2014-04       Impact factor: 9.941

Review 2.  Current and potential applications of positron emission tomography for multiple myeloma and plasma cell disorders.

Authors:  Gary A Ulaner; C Ola Landgren
Journal:  Best Pract Res Clin Haematol       Date:  2020-01-17       Impact factor: 3.020

3.  18F-FDG PET/CT in solitary plasmacytoma: metabolic behavior and progression to multiple myeloma.

Authors:  Domenico Albano; Giovanni Bosio; Giorgio Treglia; Raffaele Giubbini; Francesco Bertagna
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-08-19       Impact factor: 9.236

4.  Gastric recurrence of a primary colon plasmacytoma: staging and evaluating response to therapy with 18F-FDG PET/CT.

Authors:  W Makis; A Ciarallo; M Hickeson; R Lisbona
Journal:  Br J Radiol       Date:  2012-01       Impact factor: 3.039

Review 5.  How We Manage Patients with Plasmacytomas.

Authors:  Despina Fotiou; Meletios A Dimopoulos; Efstathios Kastritis
Journal:  Curr Hematol Malig Rep       Date:  2018-06       Impact factor: 3.952

6.  Trends and outcomes of modern staging of solitary plasmacytoma of bone.

Authors:  Rahma Warsame; Morie A Gertz; Martha Q Lacy; Robert A Kyle; Francis Buadi; David Dingli; Philip R Greipp; Suzanne R Hayman; Shaji K Kumar; John A Lust; Stephen J Russell; Thomas E Witzig; Joseph Mikhael; Nelson Leung; Steven R Zeldenrust; S Vincent Rajkumar; Angela Dispenzieri
Journal:  Am J Hematol       Date:  2012-05-02       Impact factor: 10.047

Review 7.  Solitary Plasmacytoma: a Review of Diagnosis and Management.

Authors:  Andrew Pham; Anuj Mahindra
Journal:  Curr Hematol Malig Rep       Date:  2019-04       Impact factor: 3.952

Review 8.  Role of FDG PET in the staging of multiple myeloma.

Authors:  Joao R T Vicentini; Miriam A Bredella
Journal:  Skeletal Radiol       Date:  2021-04-04       Impact factor: 2.199

9.  Mitochondrial-Targeted Decyl-Triphenylphosphonium Enhances 2-Deoxy-D-Glucose Mediated Oxidative Stress and Clonogenic Killing of Multiple Myeloma Cells.

Authors:  Jeanine Schibler; Ann M Tomanek-Chalkley; Jessica L Reedy; Fenghuang Zhan; Douglas R Spitz; Michael K Schultz; Apollina Goel
Journal:  PLoS One       Date:  2016-11-30       Impact factor: 3.240

10.  (18)F-FDG-PET/CT imaging in an IL-6- and MYC-driven mouse model of human multiple myeloma affords objective evaluation of plasma cell tumor progression and therapeutic response to the proteasome inhibitor ixazomib.

Authors:  K Duncan; T R Rosean; V S Tompkins; A Olivier; R Sompallae; F Zhan; G Tricot; M R Acevedo; L L B Ponto; S A Walsh; L T Tygrett; A J Berger; T Waldschmidt; H C Morse; J J Sunderland; S Janz
Journal:  Blood Cancer J       Date:  2013-11-29       Impact factor: 11.037
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.